Publication | Closed Access

Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients

Pharmacokinetic ModelingModel DiscriminationMedicineCystic Fibrosis PatientsOptimal DesignBiostatisticsPharmacogenomicsBiomedical ModelingPharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingComputational Medicine